VERTEX PHARMACEUTICALS INC (VRTX)

US92532F1003 - Common Stock

393.1  -1.07 (-0.27%)

After market: 393.1 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
9.87B8.93B7.57B6.21B4.16B
Minority Interest Expense
N/AN/AN/A0.000.00
Cost Of Goods
1.26B1.08B904.20M736.30M547.80M
Gross Profit
8.61B7.85B6.67B5.47B3.62B
Operating Expenses
4.78B3.53B3.89B2.61B2.42B
Research and Development
3.69B2.64B3.05B1.83B1.75B
Selling, General, and Administrative Expenses
1.14B944.70M840.10M770.50M658.50M
Operating Income
3.83B4.32B2.78B2.86B1.20B
Interest Income/Expense
563.10M-59.30M-39.50M100.30M10.00M
Other Income/Expense
-15.30M-15.70M-12.20M160.30M187.30M
Non Recurring Items
0.00-13.00M3.10M0.000.00
Income Before Taxes
4.38B4.23B2.73B3.12B1.39B
Income Tax
760.20M910.40M388.30M405.20M218.10M
Net Income
3.62B3.32B2.34B2.71B1.18B
EBITDA
4.01B4.47B2.91B2.97B1.30B
 
Per Share Data
EPS Diluted Total Ops
13.8912.829.0110.294.51
Non GAAP EPS
15.2214.8913.0210.325.33
 
Statistics
Gross Profit Margin
87.21%87.90%88.06%88.14%86.84%
Profit Margin
36.68%37.20%30.92%43.70%28.27%
Operating Profit Margin
38.83%48.38%36.73%46.03%28.77%

All data in USD

Charts